Evaluation of Patient Characteristics and Treatment Approaches to Patients With Bipolar Disorder in Turkey
NCT ID: NCT00660712
Last Updated: 2009-05-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1018 participants
OBSERVATIONAL
2008-03-31
2009-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
European Study to Describe Hospital Stay in Patients Admitted for Acute Bipolar Manic Episodes
NCT01239589
A Study Evaluating the Efficacy of Administered Maintenance Treatments in Bipolar Disorder I and II.
NCT01202604
A NIS Evaluating the Treatment Patterns of Atypical Antipsychotics in Patients Diagnosed With Bipolar I or II Disorder
NCT00888264
Evaluation of Sub-syndromal Symptoms After Acute Depressive Episode in Bipolar Disorder
NCT01663974
Improving Early Recognition and Intervention in At-risk Stages of Bipolar Disorders
NCT02456545
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Patients with bipolar disorder
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients (or any of their relatives) who give a written informed consent.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mustafa Bilici, MD, Assoc. Prof
Role: STUDY_DIRECTOR
Erenkoy State Hospital for Psychiatric Diseases, Istanbul, Turkey
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Adana, , Turkey (Türkiye)
Research Site
Afyonkarahisar, , Turkey (Türkiye)
Research Site
Ankara, , Turkey (Türkiye)
Research Site
Antalya, , Turkey (Türkiye)
Research Site
Aydin, , Turkey (Türkiye)
Research Site
Batman, , Turkey (Türkiye)
Research Site
Denizli, , Turkey (Türkiye)
Research Site
Erzincan, , Turkey (Türkiye)
Research Site
Eskişehir, , Turkey (Türkiye)
Research Site
Istanbul, , Turkey (Türkiye)
Research Site
Izmir, , Turkey (Türkiye)
Research Site
Konya, , Turkey (Türkiye)
Research Site
Malatya, , Turkey (Türkiye)
Research Site
Mardin, , Turkey (Türkiye)
Research Site
Mersin, , Turkey (Türkiye)
Research Site
Rize, , Turkey (Türkiye)
Research Site
Samsun, , Turkey (Türkiye)
Research Site
Sivas, , Turkey (Türkiye)
Research Site
Trabzon, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIS-NTR-DUM-2007/1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.